Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION (Adapted from applicant's abstract): The overall objectives of
the proposed research are to study the molecular details of the mechanisms
regulating the folding and secretion of apolipoprotein B (apo B). Apo B is
a large hydrophobic glycoprotein with unique structural properties that are
essential for the assembly and secretion of triglyceride rich lipoproteins
(very low density lipoproteins and chylomicrons) and for the
receptor-mediated catabolism of low density lipoproteins (LDL), the major
carriers of plasma cholesterol. Plasma levels of apo B are positively
correlated with an increased risk of the premature development of coronary
heart disease. The detailed mechanisms regulating the secretion of apo B
are incompletely understood. Secretion of proteins in general involve the
assistance of helper proteins: "receptors," folding enzymes and molecular
chaperones residing in the cytosol and the endoplasmic reticulum. The
hypothesis is that helper proteins that assist apo B during various stages
of its biogenesis play a crucial role in the regulation of its secretion and
are therefore relevant to the pathogenesis of the premature development of
coronary heart disease. It is further expected that one or more helper
proteins will be unique to apo B and could be targeted as a means to
modulate the secretion of apo B on VLDL. The aims of the present proposal
are to detect, identify, and characterize helper proteins mediating
translocation, folding and assembly of apo B with lipids. To that end,
cells that normally secrete lipoproteins (HepG-2), as well as
non-lipoprotein secreting cells derived from mammary tissue (C127), stably
transfected to express C-terminally truncated human apo B forms, will be
utilized. The methodology to be used involves pulse-chase protocols
followed by immunoprecipitation of cell lysates under low stringency
conditions combined with the use of cross-linking reagents. Helper proteins
will be identified using available antibodies and their mode of interaction
with apo B will be studied. Helper proteins that are unique to apo B and
that have not been identified thus far will be identified by micro
sequencing followed by searches of databases. Two categories will be
defined: a) known protein/s with a novel function or b) novel protein/s of
unknown sequence. The mode of their interaction with apo B will be studied.
No Sub Projects information available for 1R29HL058833-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R29HL058833-01
Patents
No Patents information available for 1R29HL058833-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R29HL058833-01
Clinical Studies
No Clinical Studies information available for 1R29HL058833-01
News and More
Related News Releases
No news release information available for 1R29HL058833-01
History
No Historical information available for 1R29HL058833-01
Similar Projects
No Similar Projects information available for 1R29HL058833-01